Commissioned by project Optimize, a collaboration of PATH and the World Health Organization, a study of vaccine vial monitor (VVM) availability and use in developing countries in four regions was undertaken. The study had three aspects: the total proportion of vaccines with VVMs in the regions with detailed information by country, in-depth information on policies and practices, and knowledge and attitudes in a selected sample of countries. (Source: TechNet21)
Pharmaceuticals & Biotechnology Editor | 05/26/2011
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 01 - 03, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
AI for Pharma & Healthcare
23 - 25 September, 2025
Amsterdam
Register Now |
View Agenda |
Learn More